研究發展處

Neuroscience

1. Alzheimer's Disease 62%
2. Amygdala 22%
3. Amyloid Protein 10%
4. Anterior Cingulate Cortex 8%
5. Antidepressant 13%
6. Anxiety Disorder 7%
7. Attention Deficit Hyperactivity Disorder 11%
8. Auras 8%
9. Autism 7%
10. Behavior (Neuroscience) 32%
11. Bipolar Disorder 8%
12. Blood Plasma 18%
13. Brain Age 10%
14. Brain Areas 9%
15. Brain Development 8%
16. Brain Disease 9%
17. Brain Imaging 9%
18. Brain Ischemia 13%
19. Brain Network 23%
20. Brain-Computer Interface 10%
21. Brain-Derived Neurotrophic Factor 11%
22. Cerebellum 17%
23. Cerebral Cortex 10%
24. Cerebrovascular Accident 30%
25. Cerebrovascular Disease 10%
26. Cingulate Cortex 9%
27. Cluster Headache 14%
28. Cognitive Disorders 37%
29. Cognitive Function 31%
30. Comorbidity 15%
31. Corpus Callosum 8%
32. Default Mode Network 17%
33. Depressive Disorder 12%
34. Diffusion Tensor Imaging 20%
35. Dopaminergic 10%
36. Electroencephalogram 34%
37. Electrotherapy 12%
38. Epoxide Hydrolase 8%
39. Evoked Potential 11%
40. Executive Function 9%
41. Fibromyalgia 10%
42. Fluorine-18 11%
43. Fractional Anisotropy 12%
44. Frontal Lobe 11%
45. Functional Connectivity 62%
46. Functional Magnetic Resonance Imaging 64%
47. Gamma-Aminobutyric Acid 11%
48. Gene Expression 8%
49. Glutamic Acid 13%
50. Gray Matter 19%
51. Gray Matter Volume 32%
52. Gyri 14%
53. Headache 66%
54. Heart Rate Variability 20%
55. Hippocampus 28%
56. Hypertension 8%
57. In Vitro 9%
58. In Vivo 25%
59. Interneuron 8%
60. Ketamine 11%
61. Longitudinal Study 12%
62. Magnetic Resonance Imaging 33%
63. Magnetic Resonance Imaging 33%
64. Magnetoencephalography 11%
65. Major Depressive Disorder 34%
66. Medication Overuse 8%
67. Mental Disorder 13%
68. Metabolic Pathway 10%
69. Migraine 100%
70. Mild Cognitive Impairment 32%
71. Motor Cortex 9%
72. Nervous System Disorder 8%
73. Neural Network 11%
74. Neural Stem Cell 8%
75. Neurodegenerative Disorder 11%
76. Neuronal Activity 8%
77. Nociception 14%
78. Obstructive Sleep Apnea 16%
79. Orbitofrontal Cortex 11%
80. Oxidative Stress 9%
81. Parkinson's Disease 28%
82. Pervasive Developmental Disorder 13%
83. Positron Emission Tomography 10%
84. Posterior Cingulate 9%
85. Prefrontal Cortex 11%
86. Programmed Cell Death 10%
87. Putamen 10%
88. Receptor 17%
89. Resting-State Functional Connectivity 8%
90. Sleep Quality 12%
91. Somatosensory Cortex 8%
92. Stem Cell 8%
93. Striatum 18%
94. Subjective Cognitive Decline 10%
95. Temporal Lobe 9%
96. Thalamus 19%
97. Tractography 12%
98. Transcranial Magnetic Stimulation 9%
99. Treatment-Resistant Depression 11%
100. Voxel-Based Morphometry 12%

Keyphrases

1. Age-related 10%
2. Aging 12%
3. Alzheimer's Disease 51%
4. Amygdala 12%
5. Anterior Cingulate Cortex 8%
6. Antidepressants 8%
7. Apoptosis 8%
8. Attention Deficit Hyperactivity Disorder 12%
9. Autism Spectrum Disorder 12%
10. Bipolar Disorder 9%
11. Brain Activity 10%
12. Brain Aging 9%
13. Brain Connectivity 10%
14. Brain Networks 11%
15. Brain Regions 26%
16. Brain Structure 10%
17. Brain-computer Interface 18%
18. Cerebellum 13%
19. Chronic Migraine 36%
20. CISD2 9%
21. Cluster Headache 16%
22. Cognitive Decline 14%
23. Cognitive Function 28%
24. Cognitive Impairment 26%
25. Comorbidity 11%
26. Confidence Interval 18%
27. Cortex 8%
28. Cortical Neurons 8%
29. Default Mode Network 16%
30. Dementia 20%
31. Diffusion Tensor Imaging 18%
32. Electroencephalogram 14%
33. Electroencephalography 34%
34. Episodic Migraine 10%
35. Fibromyalgia 10%
36. Fractional Anisotropy 11%
37. Functional Connectivity 41%
38. Functional Magnetic Resonance Imaging 34%
39. Gray Matter Volume 31%
40. Hazard Ratio 8%
41. Headache 30%
42. Healthy Adults 10%
43. Healthy Controls 31%
44. Heart Rate Variability 18%
45. Hepatocellular Carcinoma 8%
46. Hippocampus 18%
47. Human Brain 11%
48. Inflammation 9%
49. International Headache Society 10%
50. Intracranial Hypotension 12%
51. Ischemic Stroke 8%
52. Ketamine 10%
53. Magnetic Resonance Imaging 17%
54. Magnetoencephalography 22%
55. Major Depressive Disorder 33%
56. Medication Overuse Headache 8%
57. Menstrual Pain 9%
58. Migraine 68%
59. Migraine Patients 17%
60. Mild Cognitive Impairment 23%
61. Mini-Mental State Examination 11%
62. Motor Cortex 9%
63. National Cohort Study 16%
64. Neural Correlates 9%
65. Neural Stem Cells 8%
66. Neurodegenerative Diseases 10%
67. Neuroimaging 12%
68. Neuroinflammation 8%
69. Obstructive Sleep Apnea 17%
70. Odds Ratio 12%
71. Older Adults 20%
72. Oxidative Stress 10%
73. Parkinson's Disease 24%
74. Pathophysiology 11%
75. Positron Emission Tomography 9%
76. Primary Dysmenorrhea 10%
77. Protein Kinase 9%
78. Proteomic Analysis 9%
79. Psychiatric Disorders 8%
80. Randomized Controlled Trial 9%
81. Rat Model 8%
82. Resting State 14%
83. Resting-state Functional Connectivity (rs-FC) 10%
84. Resting-state Functional Magnetic Resonance Imaging (rs-fMRI) 23%
85. Reversible Cerebral Vasoconstriction Syndrome 25%
86. Schizophrenia 31%
87. Schizophrenic Patients 8%
88. Sex Differences 8%
89. Single nucleotide Polymorphism 8%
90. Sleep Quality 9%
91. Steady-state Visual Evoked Potential (SSVEP) 8%
92. Striatal 9%
93. Striatum 17%
94. Subjective Cognitive Decline 12%
95. Taiwan 56%
96. Taiwanese 28%
97. Treatment-resistant Depression 13%
98. Voxel-based Morphometry 12%
99. White Matter 11%
100. White Matter Hyperintensities 8%